The Boston Cancer Summit Alexion Pharmaceuticals Headquarters
Cancer R&D has never been more
promising. Yet pricing and access to this new world of cancer therapy remains
thorny. These issues have to be resolved if society is going to reap the
benefits of this work. Come hear from some of the leading scientists,
entrepreneurs, and investors about how they are thinking about the future. All
ticket proceeds go to support cancer research at Fred Hutch.
NOTE: Last year’s event sold out in advance, and space is limited. Buy your tickets early to save your seat.
1:00 p.m. | Registration
1:30 p.m. | Welcome
Rana Strellis, SVP
for global communications and culture, Alexion Pharmaceuticals
1:35 p.m. | Why I'm Doing Kilimanjaro Climb to Fight Cancer (60 seconds each)
Uciane Scarlett, associate, Atlas Venture
Katrine Bosley, biotech entrepreneur
Praveen Tipirneni, CEO, Morphic Therapeutic
Deaidra Smith, Director of Portfolio Communications, Alexion Pharmaceuticals
1:40 p.m. | New Ideas for
Cancer Treatment (10 minute slide presentations)
Simba Gill, Evelo Biosciences
(monoclonal microbials for cancer)
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.